Brian Sylvester, Wiley Rein: Cellular agriculture came to life in 2018 from Capitol Hill to the halls of the FDA and the USDA. We rounded out the year with the agencies agreeing to jointly exercise oversight. In 2019, we can look forward to further engagement from regulators as they seek to partner with stakeholders to chart a regulatory path forward, establishing greater regulatory certainty for this burgeoning sector.
2019’s regulatory conversation will focus on crafting a functioning regulatory review process, building on existing precedents – with an emphasis on pre-market assessments, inspections and labeling. Certain interests are still not quite sold on this technology and could seek to impose roadblocks through legislation or onerous rulemaking.
Therefore, stakeholders should keep a close pulse on developments at both the USDA and FDA, as well as on Capitol Hill.